Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Home Topics

Law Firm Management

THE LAST DAYS OF THE LAST DAYS

Bruce W. Marcus

Big companies, including law firms, sometimes go into bankruptcy. It happens a lot. But when it's a major law firm, like Dewey LeBoeuf, the reasons for its demise can give us some clues about the future of all law firms.

Features

Career Journal: What to Do After the Interview

Michael DeCosta

Your job interview was a success. But don't celebrate just yet ' you still have your work cut out for you.

Features

Media & Communications: Why Law Firm Marketers Don't Like PR Firms

Jamie Diaferia & Nicholas Gaffney

It's an open secret among marketers that PR agencies often engender feelings ranging from dislike to outright disdain. Among law firms especially, the criticisms are consistent. Here are some solutions.

Features

Integrated Online Marketing

Lori Chavez

There's more to online marketing than simply getting a website for your law firm or getting your business listed on Google Places. The biggest trend for 2012 is the use of integrated marketing solutions

Features

Voice of the Client: Are You Listening?

Silvia Coulter

Clients have been telling lawyers for years how to make the relationships work; what we are looking for and how to win business. Are they listening? Most of us don't think so." Here's what to do.

Features

Best Practices for ERISA ' 408(b)(2) Compliance

K. Jennie Kinnevy

To achieve the goals of the new ERISA laws, participants and sponsors will have access to more information which will increase the responsibility of plan sponsors to act upon the information received.

Features

Will Your Firm Pass a Stress Test?

Steven A. Davis, Marc Feigelson & Tyler Quinn

An annual stress test can evaluate the critical areas of firm governance, financial reporting, risk management, fiduciary practices and financial health. Monitoring these factors can help a law firm prepare to weather both internal and external threats.

INVISIBLE MARKETING - II.

allan colman, [email protected]

INVISIBLE MARKETING - II. How often do you hear people say to you when you run into them, "What's new?" It is common. Now if a client you know pretty well says to you, "What's new?", a good answer might be, "I ought to tell you about a big win one of my colleagues just had." Or, "We just opened three new offices and I can't tell you how exciting that is. We've brought in some…

Features

Expanding Your Social Network

Mark Neuberger

When used in a conscious and planned manner, social networking sites can offer a number of benefits to the firm as well as individual attorneys and staff.

Features

Competitive Law Firm Leadership

Arthur J. Levin

Many firms have recognized the need for strong business, marketing and technology management and have hired well qualified and highly compensated individuals to fill those areas of need. However, the area in which only minimal progress has occurred is in the most crucial area of Law Firm Leadership.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›